In 2025, the European healthcare sector experienced a major resurgence in mergers and acquisitions (M&A), fueled by technological innovation, demographic shifts, and strategic corporate realignments. After a quieter period in 2023 and early 2024, the market rebounded strongly, showcasing high-value deals, greater private equity (PE) participation, and a particular focus...

The biotechnology sector continues to surge ahead in 2025, driven by groundbreaking research, evolving healthcare needs, and rapid technological innovation. As the world demands more personalized, sustainable, and scalable healthcare solutions, biotech companies are stepping up with fresh strategies and transformative technologies. Here’s a look at the key biotech trends...

In a world increasingly shaped by technology, Digital Therapeutics (DTx) are revolutionizing the mental health landscape. Offering innovative, evidence-based interventions via software applications, DTx are proving to be a powerful addition — and sometimes an alternative — to traditional mental health treatments like therapy and medication. As mental health challenges...

The health sector is undergoing a profound transformation. Wearables, artificial intelligence (AI), and remote care technologies are reshaping how healthcare is delivered, accessed, and experienced. In the emerging health tech ecosystem, patients are no longer just passive recipients of care — they are active participants, empowered by smart devices and...

Clinical trials have always been the heartbeat of medical innovation—but they’re also notoriously risky, expensive, and time-consuming. For decades, investors, researchers, and pharmaceutical companies have operated under the sobering reality that most clinical trials fail. In fact, only around 9–14% of drugs that enter Phase I ever make it to...

Clinical trials have long been the engine of medical innovation — but they have also been notoriously slow, expensive, and exclusive. Now, decentralized clinical trials (DCTs) are emerging as a transformative solution, reshaping how research is conducted and who gets to participate.Driven by technological advances and accelerated by the COVID-19...

Executive Summary The European healthcare sector is experiencing a significant wave of consolidation in 2025, with mergers and acquisitions (M&A) activity surging across biotech, pharmaceuticals, medtech, and digital health.Strategic realignments, rising investor confidence, and regulatory harmonization are driving deal flow, while innovation remains a central motivation behind many transactions.This report...

Executive Summary Biotechnology in 2025 is advancing at an unprecedented pace, reshaping how we approach disease, drug development, and personalized health.Driven by mRNA, gene editing, synthetic biology, and AI-driven discovery, the biotech sector is now central to global health strategies and investment portfolios.This report highlights the breakthrough technologies, market-moving startups,...